» Articles » PMID: 21601244

Metabolic Syndrome, Urine PH, and Time-dependent Risk of Nephrolithiasis in Korean Men Without Hypertension and Diabetes

Overview
Journal Urology
Specialty Urology
Date 2011 May 24
PMID 21601244
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To examine the independent effect of metabolic syndrome (MS) on nephrolithiasis (NL) even with changes in MS status over time.

Methods: From 2002-2003, 3872 men who were reexamined annually or biannually until 2009 were enrolled in the analysis and observed for development of NL. The examination included anthropometric measurements, biochemical measurement, and kidney ultrasonography (US). A standard Cox proportional hazards model and a time-dependent Cox model were used to calculate the adjusted hazard ratio in the NL model.

Results: After adjusting for age, baseline glomerular filtration rate, and uric acid level, MS at baseline was associated with a significantly increased risk of NL (HR, 1.771; 95% confidence interval, 1.157-2.711). MS over time as a time-dependent variable also predicted the development of NL (HR, 1.678; 95% CI, 1.151-2.447) after adjusted baseline covariate. After adjustment for potential confounding factors, there was a significant stepwise increase in risk of NL, with each additional MS trait compared with those with no traits of MS at baseline and follow-up. As the numbers of MS traits at baseline and follow-up increased, the urine pH of participants at baseline and follow-up decreased significantly (P <.01). The prevalence of NL in participants with continual MS (6.6%) was higher than those with resolved MS, and continual MS was an independent factor to predict NL.

Conclusion: Our findings suggest that MS is significantly associated with increased risk of developing urine acidification, even with changes in status of MS observed during follow-up.

Citing Articles

Association between cardiometabolic index and kidney stones in US diabetic patients: NHANES 2007-2018.

Liu H, Guo M, Zhou Y, Jin M, Hao H, Yuan Y World J Urol. 2024; 42(1):653.

PMID: 39607614 DOI: 10.1007/s00345-024-05364-9.


Relationship between remnant cholesterol and risk of kidney stones in U.S. Adults: a 2007-2016 NHANES analysis.

Yao L, Yang P Ann Med. 2024; 56(1):2319749.

PMID: 38733306 PMC: 11089921. DOI: 10.1080/07853890.2024.2319749.


Causal effects of circulating lipids and lipid-lowering drugs on the risk of urinary stones: a Mendelian randomization study.

Tan Z, Hong J, Sun A, Ding M, Shen J Front Endocrinol (Lausanne). 2023; 14:1301163.

PMID: 38107516 PMC: 10722409. DOI: 10.3389/fendo.2023.1301163.


Dyslipidemia Increases the Risk of Incident Kidney Stone Disease in a Large Taiwanese Population Follow-Up Study.

Hung J, Li C, Geng J, Wu D, Chen S Nutrients. 2022; 14(7).

PMID: 35405952 PMC: 9000795. DOI: 10.3390/nu14071339.


Effect of obesity and metabolic health on urolithiasis: A nationwide population-based study.

Choi C, Kim J, Han K, Lee Y, Han J Investig Clin Urol. 2022; 63(1):63-70.

PMID: 34983124 PMC: 8756157. DOI: 10.4111/icu.20210332.